Although not tested in a pure DCM model, the cardiac-specific MCU inhibitor MCU-i4 shows promise in ischemia-reperfusion injury models, a common comorbidity in patients with diabetes. The gene discussed is MCU; the disease is familial dilated cardiomyopathy.